Written by Dr. Steve Knighton, B.Sc., D.C. — Chiropractor in Oakville, Ontario
Last reviewed: August 31st, 2026
Interest in peptides has increased dramatically in Canada. Compounds such as BPC-157, TB-500, MOTS-c, CJC-1295, ipamorelin and tesamorelin are now discussed online in connection with injury recovery, body composition, metabolism, healthy aging and athletic performance.
Every day, patients ask Dr. Steve at his Oakville clinic about the good, the bad and the ugly of peptides. This guide is exactly that — an evidence-based look at what we know, what we do not know, and what Health Canada currently says about these products.
The problem is that the popularity of these compounds has grown much faster than the human research.
Some peptides are legitimate prescription medications that have gone through formal clinical trials. Others remain experimental compounds supported mainly by laboratory or animal research. Some products marketed online as “research peptides” have specifically been identified by Health Canada as unauthorized injectable drugs.
This guide was created for people in Oakville, Halton Region and elsewhere in Canada who want a clearer answer to a simple question:
What do we actually know about these peptides, and where does the science stop?
Important educational notice: Nottinghill Family Wellness Centre does not prescribe, sell, dispense, recommend or administer peptide drugs. Prescribing drugs is outside the chiropractic scope of practice in Ontario. This article summarizes publicly available scientific and regulatory information for general education only and does not provide individualized medical advice, dosing instructions or advice on obtaining peptide products. Questions about prescription medications should be directed to an appropriately authorized healthcare professional such as a physician, nurse practitioner or pharmacist.
What Is a Peptide?
A peptide is a chain of amino acids.
Amino acids are the building blocks used by the body to construct proteins and many important signalling molecules. Peptides are generally smaller than proteins and can act as hormones, neurotransmitters, signalling molecules or components of larger biological systems.
The human body naturally produces many peptides. Insulin, glucagon-like peptide-1 (GLP-1) and growth hormone-releasing hormone (GHRH) are examples of biologically important peptide hormones.
That is why the word peptide does not automatically mean experimental, natural, safe or dangerous.
It simply describes a type of molecule.
A Health Canada-authorized peptide medication manufactured to pharmaceutical standards is very different from an experimental compound sold online under a “research use only” label.
Why Are Peptides Getting So Much Attention?
Much of the interest comes from compounds being discussed online for injury and tissue-repair research, growth hormone and IGF-1 signalling, metabolism and body composition, and exercise, performance and healthy-aging research.
The science behind these categories ranges from well-established human pharmacology to preliminary animal experiments.
That difference is essential.
A compound can have an interesting mechanism of action without having demonstrated a meaningful health benefit in humans.
Are Injectable Peptides Legal or Approved in Canada?
This is one of the most important questions for Canadian readers and Dr. Steve’s patients in Oakville.
Health Canada states that injectable peptide drugs are regulated as prescription drugs in Canada and must be authorized before they can legally be sold as prescription drugs.
Authorized prescription drugs normally carry an eight-digit Drug Identification Number, or DIN. Canadians can verify the status of a medication using Health Canada’s Drug Product Database.
Health Canada has repeatedly taken enforcement action involving unauthorized injectable peptides. In a 2025 seizure involving an online Canadian seller, the agency specifically listed BPC-157, CJC-1295, ipamorelin, MOTS-c, tesamorelin and thymosin beta-4/TB-500 among unauthorized injectable peptide products.
In April 2026, Health Canada issued another national warning about unauthorized injectable peptides sold online. In July 2026, Health Canada announced that the Superior Court of Québec had granted a permanent injunction preventing Canlab Research and its representatives from selling unauthorized injectable peptides in Canada.
Health Canada also makes an important point about the phrase “For Research Use Only – Not for Human Consumption.”
That label does not make an unauthorized drug legal or exempt it from Canadian drug regulations.
Health Canada’s April 2026 advisory on unauthorized injectable peptides specifically discusses commonly searched peptides including BPC-157, CJC-1295, ipamorelin, MOTS-C and TB-500.
Being able to find a peptide online in Canada does not mean the product is authorized by Health Canada for human use.
Are Peptides Legal in Canada?
The Short Answer
There is no single yes-or-no answer for every peptide.
Health Canada regulates injectable peptide drugs as prescription drugs in Canada. Specific peptide-containing drug products can be authorized for sale, while other peptide products remain unauthorized.
Selling an unauthorized prescription drug in Canada is illegal. Finding a peptide for sale on a Canadian website does not mean that Health Canada has authorized that product for human use.
Health Canada has specifically warned Canadians about unauthorized injectable peptide products promoted for bodybuilding, anti-aging, weight loss, athletic performance, injury recovery and general wellness.
The agency currently lists compounds including BPC-157, TB-500, MOTS-c, CJC-1295, ipamorelin, retatrutide, GHK-Cu and several others among injectable peptides being sold illegally under various names.
Health Canada also makes an important distinction about products labelled:
“For Research Use Only – Not for Human Consumption.”
That wording does not make an unauthorized drug legal and does not exempt the product from Canadian drug regulations.
For the current Health Canada guidance, see:
Health Canada: Injectable Peptide Drugs and Bodybuilding Products
Health Canada: Think Twice Before Injecting Peptides Bought Online
In July 2026, Health Canada also announced that it had obtained a permanent injunction preventing a Canadian online seller from selling unauthorized injectable peptides.
Health Canada: Permanent Injunction Against Illegal Injectable Peptide Sales
Which Peptides Are Approved by Health Canada?
This is where the terminology gets confusing.
Health Canada does not simply approve an entire category called “peptides.”
It authorizes specific drug products for specific medical uses.
An authorized prescription drug normally has an eight-digit Drug Identification Number, or DIN, which identifies the product, manufacturer, active ingredient, strength, dosage form and route of administration.
Canadians can check a medication directly in the:
Health Canada Drug Product Database
Examples of Health Canada-Authorized Peptide-Based Medications
There are many legitimate peptide and peptide-based prescription medications used in Canadian medicine.
Examples include:
| Active Ingredient | Examples of Authorized Canadian Products | General Medical Use |
|---|---|---|
| Semaglutide | Wegovy, Ozempic, Rybelsus and authorized generic products | Weight management and/or type 2 diabetes depending on the specific product |
| Tirzepatide | Zepbound, Mounjaro | Weight management and/or type 2 diabetes depending on the specific product |
| Liraglutide | Saxenda, Victoza | Weight management and/or type 2 diabetes depending on the specific product |
| Insulin | Multiple Health Canada-authorized insulin products | Diabetes management |
This is not a complete list of peptide medications in Canada.
The important point is that a regulated prescription medication such as Wegovy or Mounjaro is completely different from an experimental vial of BPC-157 or TB-500 being sold online.
Health Canada authorized Canada’s first generic semaglutide injection for weight management in June 2026, another example of how individual peptide-based drug products go through a formal regulatory process.
Health Canada: Canada Approves First Generic Semaglutide for Weight Loss
Which Popular Peptides Are Not Approved by Health Canada?
This is probably the more useful question for people researching peptides online.
Several compounds heavily discussed in gyms, podcasts, bodybuilding forums, social media and anti-aging circles have been identified by Health Canada in connection with unauthorized injectable peptide products.
| Commonly Searched Peptide | Canadian Regulatory Context |
|---|---|
| BPC-157 | Identified by Health Canada among unauthorized injectable peptide drugs |
| TB-500 / thymosin beta-4 products | Identified in Health Canada warnings and enforcement involving unauthorized injectable peptide products |
| MOTS-c | Identified by Health Canada among unauthorized injectable peptide products |
| CJC-1295 | Identified by Health Canada among unauthorized injectable peptide drugs |
| Ipamorelin | Identified by Health Canada among unauthorized injectable peptide drugs |
| Retatrutide | Identified by Health Canada among unauthorized injectable peptide products |
| GHK-Cu injectable products | Identified by Health Canada among unauthorized injectable peptide products |
| Tesamorelin sold through unauthorized online sources | Should not be assumed to be authorized simply because tesamorelin has previously existed as a regulated prescription drug product |
This distinction matters.
BPC-157 having interesting animal research does not make it a Health Canada-approved tendon treatment.
CJC-1295 increasing growth hormone and IGF-1 in human research does not mean an online vial of CJC-1295 is an authorized Canadian medication.
A Canadian website selling TB-500 does not make TB-500 a Health Canada-approved injury-recovery treatment.
And “research grade” does not mean pharmaceutical grade.
Patients ask Dr. Steve about peptides regularly because they are now everywhere online. As an Ontario chiropractor, he does not prescribe peptide drugs or tell patients which peptide medication they should take. Medication-specific questions are directed to an appropriately authorized healthcare professional such as a physician, nurse practitioner or pharmacist.
The purpose of this guide is to separate three very different questions:
- What is the peptide supposed to do?
- What has actually been demonstrated in human research?
- What is its current regulatory status in Canada?
Those are three different questions, and mixing them together is where a lot of the confusion around peptides begins.
Are There Health Canada-Approved Peptide Medications for Weight Loss?
Yes. Some peptide-based medications are approved by Health Canada for weight management, but these are very different from the experimental or “research” peptides commonly discussed online.
Medications such as semaglutide and tirzepatide work through hormone-related pathways involved in appetite, blood sugar regulation and digestion. These medications have undergone clinical trials, are manufactured as regulated pharmaceutical products and require a prescription when used in Canada.
This is an important distinction when discussing peptides.
A medication being described as a “peptide” does not automatically mean it is experimental. At the same time, the existence of approved peptide medications does not mean that other peptides — such as BPC-157, TB-500, CJC-1295 or ipamorelin — have the same approval, evidence or regulatory status.
For Canadians researching peptides online, one of the most useful questions to ask is:
Is the specific product approved by Health Canada for the purpose it is being promoted for?
Approved prescription medications have defined manufacturing standards, dosing information, known indications and ongoing safety monitoring. Products sold online as “research peptides” may not have those same safeguards.
Patients considering medication for weight loss should discuss the available evidence-based options with a physician, nurse practitioner or other qualified prescriber rather than assuming that all products marketed as peptides are interchangeable.
Quick Comparison of Six Commonly Searched Peptides
| Peptide | Main Research Interest | Human Evidence | Canadian Regulatory Context |
|---|---|---|---|
| BPC-157 | Tissue repair, tendon, ligament and muscle research | Very limited | Identified by Health Canada in unauthorized injectable peptide enforcement |
| TB-500 / thymosin beta-4 related compounds | Cell migration, angiogenesis and tissue repair | Human work exists for full-length thymosin beta-4 in other conditions; orthopaedic TB-500 evidence is lacking | Identified in Health Canada enforcement |
| MOTS-c | Mitochondrial signalling, metabolism and exercise | Human biology data exist; therapeutic administration evidence remains very limited | Identified by Health Canada as an unauthorized injectable peptide |
| CJC-1295 | Growth hormone and IGF-1 stimulation | Controlled human endocrine studies exist | Identified by Health Canada as an unauthorized injectable peptide |
| Ipamorelin | Ghrelin-receptor signalling and growth hormone release | Human pharmacology and clinical-trial data exist, but not for common online performance claims | Identified by Health Canada as an unauthorized injectable peptide |
| Tesamorelin | GHRH signalling and visceral adipose tissue | Substantial randomized human evidence for a specific HIV-associated indication | EGRIFTA was previously marketed in Canada; current Health Canada DIN entries are cancelled |
Why Include the “Gym-Bro” Explanation?
A large amount of peptide information now spreads through gyms, podcasts, bodybuilding forums and social media. Those discussions are useful for understanding why a compound became popular, but popularity and biological plausibility are not the same as clinical evidence. Throughout this guide, we separate the common internet theory from what has actually been demonstrated in human research.
BPC-157
What Is BPC-157?
BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence associated with a gastric protein sometimes referred to in the research literature as body protection compound.
It has become one of the most heavily discussed experimental peptides in sports and musculoskeletal recovery circles.
Common online claims include faster recovery from tendon injuries, ligament injuries, muscle injuries, joint pain and surgical procedures.
Those claims are much stronger than the current human evidence.
How Might BPC-157 Work?
Most proposed mechanisms come from laboratory and animal research.
Preclinical studies have investigated possible effects involving angiogenesis, endothelial-cell function, growth-factor signalling, inflammatory cytokines, nitric-oxide pathways, fibroblast activity and cellular pathways involved in tissue repair.
A 2025 systematic review of BPC-157 in orthopaedic sports medicine found 36 eligible studies.
Thirty-five were preclinical studies. Only one was a human clinical report.
Animal models reported improvements in some measures of muscle, tendon, ligament and bone healing, but animal injury models cannot establish that the same effect occurs in people.
Does BPC-157 Heal Tendons in Humans?
There is currently no strong randomized human evidence demonstrating that BPC-157 accelerates tendon healing.
The single human musculoskeletal study identified in the 2025 systematic review was a small retrospective report involving chronic knee pain. Seven of 12 patients reported prolonged pain relief after intra-articular BPC-157, but the study lacked the design needed to determine whether BPC-157 caused the improvement.
The current evidence can reasonably be summarized as:
Preclinical evidence: interesting.
Human musculoskeletal evidence: extremely limited.
Large randomized trials showing faster tendon or ligament healing: not established.
Is BPC-157 Approved in Canada?
Health Canada has identified BPC-157 among unauthorized injectable peptide drugs marketed or seized in Canada.
It should not be described as a Health Canada-approved tendon-healing or injury-recovery treatment.
What Is Still Unknown About BPC-157?
Important unanswered questions include long-term human safety, clinically meaningful effectiveness, drug interactions, effects in people with chronic disease, whether animal tissue-healing findings translate to humans and product quality when obtained outside regulated pharmaceutical channels.
The lack of reliable human safety data is particularly important because an experimental compound can appear promising in animals while producing unexpected effects in people.
BPC-157 — Gym-bro theory: “This is the injury-healing peptide.” People online claim it speeds tendon, ligament, muscle and sometimes gut healing and gets athletes back training faster. Reality: that reputation comes primarily from animal/preclinical research; convincing human tendon-healing evidence doesn’t exist yet.
TB-500 and Thymosin Beta-4
What Is Thymosin Beta-4?
Thymosin beta-4, often abbreviated Tβ4, is a naturally occurring 43-amino-acid peptide found in many human tissues and body fluids.
It binds actin, an important structural protein inside cells, and has been studied in connection with cell migration, angiogenesis, inflammatory signalling, extracellular-matrix remodelling, wound repair and tissue protection.
Unlike many internet discussions suggest, thymosin beta-4 is a legitimate area of biomedical research.
Human clinical research has even investigated pharmaceutical thymosin beta-4 in areas such as chronic dermal wounds.
Is TB-500 the Same as Thymosin Beta-4?
Not exactly.
The name TB-500 is commonly used commercially for a synthetic peptide or fragment related to thymosin beta-4.
This distinction matters.
A study of pharmaceutical full-length thymosin beta-4 in a chronic skin wound cannot automatically be used as proof that a vial marketed as TB-500 will repair an Achilles tendon, rotator cuff or ligament injury.
The molecule, formulation, route, manufacturing quality, condition being treated and study population all matter.
Does TB-500 Heal Tendons or Ligaments?
Human orthopaedic evidence is lacking.
Research on thymosin beta-4 supports plausible mechanisms involving angiogenesis, cell migration and tissue repair, but a 2026 review of injectable peptides in orthopaedic and sports medicine concluded that TB-4/TB-500 research supporting musculoskeletal repair remains predominantly preclinical.
There is a scientific rationale worth studying, but the clinical claims seen online are ahead of the human evidence.
Is TB-500 Approved in Canada?
Health Canada has identified thymosin beta-4/TB-500 products in enforcement actions involving unauthorized injectable peptides.
Being marketed in Canada does not mean a TB-500 product has been authorized for human use.
TB-500 — Gym-bro theory: “This is the systemic recovery peptide.” The theory is that it improves tissue repair, mobility and recovery throughout the body rather than at one specific injured area. Reality: there is interesting thymosin beta-4 biology, but that doesn’t establish that commercial TB-500 injections repair human musculoskeletal injuries.
What Is the Wolverine Stack?
The Wolverine Stack is an informal internet term usually referring to:
BPC-157 + TB-500
The nickname comes from the fictional character Wolverine and his rapid healing ability.
It is not the name of an established medical treatment.
Has the Wolverine Stack Been Studied in Humans?
There is no strong randomized human evidence demonstrating that the BPC-157/TB-500 combination accelerates tendon, ligament, muscle or surgical healing.
Internet discussions sometimes reason that if each compound has an interesting biological mechanism, using the two together should be more effective.
That conclusion does not follow automatically.
Combining two experimental compounds creates additional questions involving the safety of each compound, interactions between the compounds, pharmacokinetics, product quality and whether any observed change is clinically meaningful.
At present, “Wolverine Stack” should be understood as an internet nickname rather than an evidence-based medical protocol.
Wolverine Stack — Gym-bro theory: “BPC-157 fixes the injured area and TB-500 improves healing everywhere, so combining them should heal you even faster.” Reality: that’s a hypothesis created largely by peptide culture. We don’t have good human trials proving the combination produces that result.
MOTS-c
What Is MOTS-c?
MOTS-c is one of the most scientifically unusual peptides in this group.
The name stands for:
Mitochondrial Open Reading Frame of the 12S rRNA type-c.
MOTS-c is a 16-amino-acid peptide encoded within mitochondrial DNA.
Mitochondria are commonly described as the energy-producing structures inside cells, but modern research shows that they also participate in signalling throughout the body.
MOTS-c appears to be one of those mitochondrial signalling molecules.
How Does MOTS-c Work?
The original 2015 Cell Metabolism research found that MOTS-c influenced folate and purine metabolism and increased levels of AICAR, a cellular metabolite capable of activating AMP-activated protein kinase, or AMPK.
AMPK acts as an important cellular energy sensor.
When energy availability falls, AMPK helps shift cells toward energy-producing processes and away from some energy-consuming processes.
Experimental MOTS-c research has therefore focused on glucose metabolism, insulin sensitivity, skeletal-muscle metabolism, mitochondrial function, metabolic stress, AMPK signalling and exercise adaptation.
This is why MOTS-c sometimes gets described online as an “exercise mimetic.”
That phrase should be interpreted cautiously.
Does MOTS-c Improve Exercise Performance?
The strongest performance findings are from animal research.
A 2021 study reported that administered MOTS-c improved physical performance in mice of different ages. The same study also found that exercise increased the body’s own MOTS-c expression in human skeletal muscle and circulation.
Those findings demonstrate two different things:
- administered MOTS-c affected performance in mice; and
- naturally produced MOTS-c changed during exercise in humans.
They do not establish that injecting MOTS-c improves exercise performance in people.
A 2026 study added more preclinical evidence involving mitochondrial bioenergetics and AMPK/PGC-1α-dependent pathways, but therapeutic human evidence remains limited.
Is MOTS-c Approved in Canada?
Health Canada has identified MOTS-c among unauthorized injectable peptide products.
It should currently be viewed as an experimental research compound rather than an established Canadian metabolic or exercise therapy.
MOTS-c — Gym-bro theory: “Exercise in a vial.” You’ll see claims about endurance, mitochondrial function, insulin sensitivity, energy and easier fat loss. Reality: the mitochondrial/AMPK science is genuinely fascinating and animal performance findings are interesting, but externally administered MOTS-c has nowhere near enough human evidence to call it an exercise replacement or proven performance enhancer.
CJC-1295
What Is CJC-1295?
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, or GHRH.
GHRH is normally produced in the hypothalamus and signals the pituitary gland to release growth hormone.
Growth hormone subsequently influences many tissues and stimulates production of insulin-like growth factor-1, or IGF-1.
CJC-1295 was designed to produce longer-lasting stimulation of this pathway than naturally occurring GHRH.
Does CJC-1295 Increase Growth Hormone?
Yes. This is one of the areas where actual controlled human evidence exists.
A randomized, double-blind, placebo-controlled study in healthy adults found that a single administration of CJC-1295 produced dose-dependent increases in circulating growth hormone and IGF-1 lasting for several days.
That establishes an important pharmacological point:
CJC-1295 can stimulate the human GH/IGF-1 axis.
But it does not establish every claim attached to CJC-1295 online.
Showing that a compound raises GH and IGF-1 is different from proving that it safely increases muscle mass, accelerates injury recovery, produces meaningful fat loss, reverses aging or improves long-term health.
Those outcomes require their own clinical trials.
Is CJC-1295 the Same as HGH?
No.
Human growth hormone, or HGH, is growth hormone itself.
CJC-1295 acts upstream by mimicking GHRH and stimulating the pituitary gland to release more endogenous growth hormone.
Is CJC-1295 Approved in Canada?
Health Canada has specifically identified CJC-1295 among unauthorized injectable peptide drugs.
It is important not to confuse evidence that it affects human growth-hormone physiology with evidence that an online CJC-1295 product is authorized for sale in Canada.
CJC-1295 + ipamorelin — Gym-bro theory: “Increase your own GH instead of injecting growth hormone.” People associate the combination with better sleep, recovery, muscle growth and fat loss. Reality: both have biological evidence for affecting growth-hormone signalling, but demonstrating an increase in GH/IGF-1 is not the same thing as proving all those downstream physique and recovery claims.
Ipamorelin
What Is Ipamorelin?
Ipamorelin is a synthetic growth hormone secretagogue.
It acts primarily at the ghrelin receptor, also known as the growth hormone secretagogue receptor or GHSR-1a.
Ghrelin participates in appetite, gastrointestinal function and growth-hormone secretion.
By stimulating this receptor, ipamorelin can produce a pulse of growth-hormone release.
Has Ipamorelin Been Studied in Humans?
Yes.
A human pharmacokinetic and pharmacodynamic study in healthy volunteers demonstrated that ipamorelin produced a measurable episode of growth-hormone release.
Ipamorelin has also been studied for purposes unrelated to bodybuilding or anti-aging.
A multicentre, randomized, double-blind Phase 2 study evaluated ipamorelin as a treatment for postoperative ileus following bowel surgery.
The study demonstrates an important principle in drug research:
A compound can affect its intended biological pathway without proving clinically useful for a particular condition.
Ipamorelin showed pharmacological activity, but the Phase 2 postoperative study did not establish the broad clinical benefits commonly claimed for it online.
What Is the Difference Between CJC-1295 and Ipamorelin?
Both influence growth-hormone secretion, but through different receptors.
CJC-1295: primarily works through the GHRH receptor pathway.
Ipamorelin: primarily works through the ghrelin/GHSR pathway.
This is the biological rationale behind the frequently marketed combination of CJC-1295 plus ipamorelin.
Does CJC-1295 Plus Ipamorelin Work Better Together?
The combination is popular online, but popularity is not the same as clinical evidence.
Human studies demonstrate that the individual compounds can influence growth-hormone physiology.
There is not a strong body of randomized human evidence establishing that the commonly marketed CJC-1295/ipamorelin combination safely improves muscle growth, recovery, fat loss, healthy aging or athletic performance.
Is Ipamorelin Approved in Canada?
Health Canada has identified ipamorelin among unauthorized injectable peptide drugs sold in Canada.
Tesamorelin
What Is Tesamorelin?
Tesamorelin is a synthetic analogue of GHRH.
Like CJC-1295, it stimulates the pituitary gland and increases endogenous growth-hormone signalling, which subsequently increases IGF-1.
Tesamorelin is different from most compounds on this page because it has a substantial pharmaceutical history and has been studied in large randomized human trials.
What Was Tesamorelin Developed to Treat?
Tesamorelin was developed for HIV-associated lipodystrophy, particularly excess visceral abdominal fat in adults living with HIV.
This is a very specific medical indication.
It was not developed as a general weight-loss medication, bodybuilding peptide, anti-aging treatment or injury-recovery drug.
That distinction matters when interpreting tesamorelin research.
Does Tesamorelin Reduce Visceral Fat?
For the patient population in which it was studied, randomized human evidence shows that it can.
Large placebo-controlled trials demonstrated reductions in visceral adipose tissue in adults living with HIV who had excess abdominal fat.
A 2026 systematic review and meta-analysis pooling four randomized controlled trials and 909 participants found significant reductions in visceral adipose tissue, waist circumference and trunk fat, with an increase in lean body mass.
Those are legitimate human clinical data.
They should not automatically be extrapolated to healthy people seeking cosmetic abdominal fat loss or athletic enhancement.
Is Tesamorelin a Weight-Loss Drug?
Not in the ordinary sense.
The original therapeutic target was visceral adipose tissue, not overall body weight.
Clinical research found meaningful changes in abdominal visceral fat without establishing tesamorelin as a general obesity treatment.
“Reduced visceral fat in a defined HIV population” is scientifically different from “proven weight-loss peptide.”
What Are the Main Tesamorelin Safety Considerations?
Tesamorelin stimulates growth-hormone and IGF-1 signalling, so safety monitoring in clinical research has focused on issues associated with that hormonal pathway.
Published trials and product information have discussed adverse effects including injection-site reactions, joint discomfort, muscle discomfort, paresthesia or nerve-type symptoms, fluid-retention-related symptoms, changes in glucose regulation and elevated IGF-1.
Because growth-hormone/IGF-1 pathways participate in cell growth, medical product information has also included important precautions relating to malignancy.
These considerations are one reason hormone-modifying peptides should not be treated like ordinary nutritional supplements.
Was Tesamorelin Approved in Canada?
Tesamorelin has a genuine Canadian pharmaceutical history.
Health Canada’s Drug Product Database lists EGRIFTA, containing tesamorelin, as a prescription drug that was previously marketed in Canada.
However, the current database status is important:
EGRIFTA 1 mg, DIN 02438712: Cancelled Post Market, status date September 30, 2022.
EGRIFTA 2 mg, DIN 02423677: Cancelled Pre Market, status date July 13, 2023.
The “Cancelled Post Market” entry does not itself mean that Health Canada cancelled the product for a safety problem. Health Canada explains that this status can occur after a manufacturer discontinues sale of a product.
The key point for a Canadian reader is that older statements saying “EGRIFTA is approved in Canada” do not fully describe its current Drug Product Database status.
Tesamorelin — Gym-bro theory: “The belly-fat peptide.” This one gets attention because there are actual studies showing reductions in visceral fat. Reality: this is where context becomes crucial—the strong trials were conducted in people with HIV-associated lipodystrophy, not ordinary healthy gym-goers trying to get leaner.
What Does “Research Use Only” Mean for Peptides in Canada?
Many online peptide websites use language such as “For Research Use Only” or “Not for Human Consumption.”
Health Canada specifically warns that this wording does not exempt a product from Canadian drug regulation.
If a substance is being sold or represented as an injectable drug for human use, a research label does not transform it into an authorized Canadian medication.
This is especially important because consumers may incorrectly interpret “research grade” as meaning pharmaceutical grade.
Those are not equivalent concepts.
Does 99% Peptide Purity Mean a Product Is Safe?
No.
Even if an independent laboratory accurately measured the chemical purity of a peptide, purity alone would not establish sterility, correct vial concentration, correct molecular identity, freedom from contaminants, stability during shipping and storage, appropriate manufacturing controls, human safety, effective dosing, drug interactions or clinical effectiveness.
A product can be chemically pure and still be unsafe or clinically unproven.
What Is a DIN and Why Does It Matter?
DIN stands for Drug Identification Number.
Health Canada assigns an eight-digit DIN to drug products that have been authorized for sale after the regulator evaluates information about the product.
Consumers can use Health Canada’s Drug Product Database to search a medication by product name, active ingredient or DIN.
This is a much more reliable way to investigate Canadian authorization than relying on statements made by an online seller.
Health Canada also recommends checking its Drug Product Database to confirm whether a drug has been authorized for sale in Canada.
Can a Chiropractor Prescribe Peptides in Ontario?
No.
Prescribing a drug is outside the chiropractic scope of practice in Ontario.
The College of Chiropractors of Ontario’s current Standard of Practice S-001 addresses general health-related questions involving controlled acts outside chiropractic scope, specifically including prescribing drugs.
CCO states that in these situations a chiropractor must make it clear that the act is outside chiropractic scope and that the patient requires, or would be more appropriately treated by, a healthcare professional with that act within their scope.
The chiropractor may respond to general questions in a professional, accurate and balanced manner while encouraging informed healthcare decisions.
That is the purpose of this page.
Nottinghill Family Wellness Centre does not prescribe or administer peptide drugs.
What Are the Risks of Buying Unauthorized Injectable Peptides Online?
The risk is not limited to whether the peptide molecule itself eventually proves useful.
Health Canada warns that unauthorized drugs have not been assessed for the same combination of safety, effectiveness and quality required of authorized medications.
Potential concerns therefore include both drug-related risk and product-quality risk.
Health Canada has warned of serious potential harms from unauthorized injectable peptides, including hormonal and blood-sugar disturbances and other systemic effects.
There is also the practical uncertainty of whether an unauthorized vial contains exactly what its label claims.
Are Peptides Banned in Competitive Sports?
Competitive athletes need additional caution.
The World Anti-Doping Agency’s 2026 Prohibited List specifically includes several peptide-related substances or classes relevant to this discussion.
Examples include CJC-1295 and tesamorelin under growth hormone-releasing hormone analogues, ipamorelin under growth hormone secretagogues, and thymosin beta-4 and derivatives such as TB-500 under growth-factor-related substances.
WADA also maintains a category for non-approved substances.
Athletes subject to anti-doping rules should verify any medication or compound through appropriate anti-doping resources rather than assuming that a substance is permitted because it is sold online.
FAQs About Peptides in Canada
Is BPC-157 legal in Canada?
Health Canada has identified injectable BPC-157 among unauthorized injectable peptide drugs sold or seized in Canada. BPC-157 should not be described as a Health Canada-authorized injury, tendon-healing or recovery treatment. Selling unauthorized prescription drugs in Canada is illegal, and availability from a Canadian website does not mean that a product has been authorized by Health Canada.
Does BPC-157 actually heal tendons?
Animal research is promising enough to justify further study, but strong human evidence demonstrating faster tendon healing is currently lacking.
What is TB-500?
TB-500 is a name used for a synthetic peptide or fragment related to thymosin beta-4, an endogenous peptide involved in actin binding, cell migration and tissue-repair biology.
Is TB-500 the same as thymosin beta-4?
Not exactly. Full-length thymosin beta-4 and products marketed as TB-500 should not be treated as interchangeable when interpreting clinical research.
What is the Wolverine Stack?
The Wolverine Stack is an informal name usually referring to BPC-157 plus TB-500. It is not a recognized Health Canada-approved medical treatment.
Has the Wolverine Stack been proven to speed injury recovery?
No strong randomized human trials have established that the BPC-157/TB-500 combination accelerates musculoskeletal healing.
What does MOTS-c stand for?
MOTS-c stands for Mitochondrial Open Reading Frame of the 12S rRNA type-c. It is a 16-amino-acid peptide encoded within mitochondrial DNA.
Is MOTS-c an exercise replacement?
No. Animal research has investigated administered MOTS-c and exercise performance, while human studies have examined the body’s naturally occurring MOTS-c response to exercise. That does not establish injected MOTS-c as a substitute for exercise in humans.
Is CJC-1295 the same as growth hormone?
No. CJC-1295 is a GHRH analogue that stimulates the body’s own growth-hormone axis. Growth hormone itself is a different molecule.
Does CJC-1295 increase IGF-1?
Controlled human research has shown that CJC-1295 can increase circulating growth hormone and IGF-1. That pharmacological effect does not prove all of the anti-aging, recovery or body-composition claims made online.
What does ipamorelin do?
Ipamorelin activates the ghrelin/growth-hormone secretagogue receptor and can stimulate a pulse of growth-hormone release.
Why are CJC-1295 and ipamorelin combined?
They influence growth-hormone secretion through different receptor pathways, which provides a theoretical reason for combining them. Strong clinical evidence for the common online combination remains limited.
Is tesamorelin the same as CJC-1295?
No. Both are related to GHRH signalling, but they are different molecules with different pharmaceutical histories and evidence bases.
Does tesamorelin burn belly fat?
Randomized trials demonstrated reductions in visceral abdominal fat in adults living with HIV-associated abdominal fat accumulation. Those findings should not automatically be generalized to healthy people seeking cosmetic fat loss.
Is tesamorelin currently approved in Canada?
EGRIFTA was previously marketed in Canada as a prescription tesamorelin product. Health Canada’s current Drug Product Database lists the 1 mg product as Cancelled Post Market and the 2 mg product as Cancelled Pre Market.
How Much Do Peptides Cost in Canada?
There is no single price for “peptides” in Canada because the term includes everything from approved prescription medications to experimental products sold online.
The cost of a legitimate prescription peptide medication can vary depending on the specific medication, dose, pharmacy and whether part of the cost is covered by a private insurance plan.
Prices advertised online for products such as BPC-157, TB-500 or other research peptides should not be used as an indication of their quality or safety. A higher price does not mean a product is Health Canada approved, pharmaceutical grade, sterile or proven to work.
If you are considering a peptide-based medication, the more important questions are whether the specific product is authorized in Canada, what evidence supports its use and whether it is being prescribed and monitored appropriately.
Does “research grade” mean pharmaceutical grade?
No. Research-use terminology does not establish that a product meets the manufacturing, sterility, quality and regulatory requirements of an authorized prescription medication.
If a Canadian website sells a peptide, is it Health Canada approved?
No. Availability from a Canadian website and authorization by Health Canada are completely different things. Check for a valid DIN and verify the product in Health Canada’s Drug Product Database.
Can a chiropractor recommend or prescribe peptide drugs in Ontario?
Prescribing drugs is outside chiropractic scope in Ontario. Medication-specific assessment, prescribing and monitoring should be handled by an appropriately authorized healthcare professional.
The Biggest Problem With the Peptide Conversation
Peptide discussions frequently blend together three different levels of evidence.
1. Biological Plausibility
A molecule may interact with a receptor, enzyme or signalling pathway that makes an effect scientifically plausible.
That is useful information.
It is not proof of a clinical benefit.
2. Preclinical Research
Animal and laboratory research can demonstrate what might be possible and help researchers decide whether human trials are justified.
It cannot establish that a treatment is effective in people.
3. Human Clinical Outcomes
Ultimately, claims about pain, healing, body composition, athletic performance or long-term health require appropriately designed human studies.
This is the step that is missing for many of the most heavily marketed peptides.
A mouse tendon healing faster does not prove a human Achilles tendon will heal faster.
An increase in growth hormone does not prove longer life.
A naturally occurring peptide increasing during exercise does not prove that injecting the peptide reproduces the benefits of exercise.
And a product being available for purchase does not mean Health Canada has authorized it.
How Should You Evaluate a Peptide Claim?
Instead of asking only “What does this peptide do?”, ask whether the mechanism has been identified, whether results exist only in cells or animals, whether the actual compound has been administered to humans, whether a placebo or control group was used, whether the outcome was clinically meaningful, how many people were studied, whether long-term safety data exist, whether the exact product is authorized by Health Canada and whether the evidence actually applies to the condition or goal being discussed.
This framework helps separate interesting science from confident marketing.
Related Oakville Musculoskeletal Guides
People sometimes arrive at peptide information while researching persistent musculoskeletal pain or an injury.
For evidence-based information on common conditions, see:
Low Back Pain Treatment in Oakville
Shoulder Pain Treatment in Oakville
Sciatica Treatment in Oakville
These pages discuss conservative musculoskeletal assessment and care. They are not peptide-treatment pages.
Bottom Line for Oakville Patients
Peptide science is a legitimate and rapidly developing field of biomedical research.
The problem is that the evidence varies enormously from one compound to another.
BPC-157 has interesting preclinical musculoskeletal data, but human evidence remains extremely limited.
TB-500 and thymosin beta-4 involve legitimate tissue-repair biology, but research involving full-length thymosin beta-4 should not be used as proof that commercial TB-500 injections heal musculoskeletal injuries.
MOTS-c is a fascinating mitochondrial signalling peptide with important metabolic and exercise research, but therapeutic human evidence remains limited.
CJC-1295 and ipamorelin have demonstrated measurable effects on human growth-hormone physiology, while many broader recovery, body-composition and anti-aging claims remain inadequately established.
Tesamorelin has by far the strongest human clinical history in this group, including randomized trials for HIV-associated visceral fat accumulation, but those findings apply to a specific medical population and its former Canadian EGRIFTA products currently have cancelled DIN status.
For people in Oakville or anywhere else in Canada researching peptide drugs, the most useful distinction may be the simplest:
Interesting science does not automatically equal established treatment.
Understanding where the evidence ends is just as important as understanding where it begins.
Sources and Further Reading
Health Canada — Think twice before injecting peptides bought online: unauthorized products can seriously harm you.
Health Canada — Permanent injunction preventing Canlab Research’s illegal sale of injectable peptides in Canada.
Health Canada — Unauthorized injectable peptide drugs seized and sold by Canada Peptide.
College of Chiropractors of Ontario — Standard of Practice S-001: Chiropractic Scope of Practice.
College of Chiropractors of Ontario — Guideline G-016: Communication to the Public.
Vasireddi N, et al. — Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
Goldstein AL, et al. — Thymosin beta-4 and dermal healing research.
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Lee C, et al. — MOTS-c, metabolic homeostasis, obesity and insulin resistance.
Reynolds JC, et al. — MOTS-c, exercise and age-dependent physical decline.
Gudiksen A, et al. — MOTS-c and mitochondrial bioenergetics.
Teichman SL, et al. — CJC-1295, growth hormone and IGF-1 in healthy adults.
Ipamorelin pharmacokinetic/pharmacodynamic study in human volunteers.
Randomized Phase 2 ipamorelin postoperative ileus trial.
2026 systematic review and meta-analysis of tesamorelin in HIV-associated lipodystrophy.
Health Canada Drug Product Database — EGRIFTA 1 mg and 2 mg.
World Anti-Doping Agency — 2026 Prohibited List.